Medical writing built for AI retrieval.

Front-load the answer, cite your source in the same sentence, and publish in indexed HTML. Those three rules move a piece of pharma content from invisible to citable in retrieval systems. The research behind each rule is specific and quantified. GEO adds a third audience to the two medical writing already serves — the human reader and the regulatory reviewer — and that third audience, the retrieval engine, has preferences that are more aligned with good clinical writing than with SEO. Precise language, canonical claims, and well-referenced content are both good MLR practice and good GEO practice.

The 44.2% front-loading rule and what it means for medical writing structure

The single most actionable finding in the retrieval research literature is the front-loading rule, derived from an analysis of 1.2 million ChatGPT responses. According to Kevin Indig's study published in Search Engine Land, 44.2% of citations drawn from a source document come from the first 30% of that document's content. The majority of what gets cited is what appears earliest.

For medical writing, this has a direct structural implication. The standard medical writing structure — Background, Methods, Results, Discussion, Conclusion — front-loads context and back-loads conclusions. The retrieval engine inverts this preference: it samples most heavily from the top of the document and disproportionately cites the material that appears there. A piece written in the traditional structure will have its methodology cited at high rates and its clinical conclusions cited at low rates, because the conclusions appear in the final 30% of the content.

The fix is not radical. It is the same front-loading that journalism has practiced for a century: put the answer first, then the supporting evidence. For retrieval-oriented medical content, this means the h1 and the first two paragraphs should contain the primary clinical claim, the key data point with its source, and the approved indication or population. Everything that follows supports, qualifies, or expands that opening. The MLR implication is minor — the claims are identical; only their order changes.

What the Princeton paper proves about content structure and rank

The front-loading rule is reinforced by academic findings on what content features specifically improve retrieval ranking. The Princeton GEO paper (Aggarwal et al., NeurIPS 2024, arXiv 2311.09735) measured the effect of specific textual interventions on Position-Adjusted Word Count (PAWC) — how much of a source's content an LLM incorporates into its answers:

The literature floor: why PMC-indexed publication is a prerequisite

Every therapeutic area tracked in the May 2026 PharmaGEO public index shows pmc.ncbi.nlm.nih.gov (PubMed Central) in its top citation sources. In atopic dermatitis, PMC generates 94 source uses in Perplexity responses. In psoriasis, it is the top source at 154 uses. This is not a coincidence — it reflects a retrieval architecture that treats PMC-indexed literature as the credibility baseline for pharma claims (insight E3, May 2026 PharmaGEO public index).

The operational implication: if a brand's clinical evidence is not accessible through PMC-indexed journals, retrieval engines have no path to cite it. A Phase 3 trial published behind a paywall without an open-access PMC version is retrievable by neither Perplexity (which surfaces explicit source links) nor ChatGPT (which draws on indexed content). Ensuring that at least the primary Phase 3 manuscript, a key secondary analysis, and any relevant subgroup papers are PMC-accessible is the minimum viable publication strategy for GEO.

A before/after rewrite: what retrieval-friendly medical writing looks like in practice

The difference between retrievable and non-retrievable medical writing is often in the same paragraph. The following example shows a weak version and a retrieval-optimised version of the same clinical claim.

Before: standard paragraph structure

"Clinical trials have demonstrated that this medication provides meaningful benefit for patients with moderate-to-severe disease. In studies, patients treated with the drug showed significant improvements across multiple endpoints compared to those who received placebo, with a generally acceptable tolerability profile observed over the treatment period."

This paragraph is MLR-safe but retrieval-invisible. It contains no trial name, no numeric result, no population specificity, no source attribution, and no front-loaded answer. A retrieval engine cannot extract a citable claim from it because there is no citable claim — only vague affirmations.

After: retrieval-optimised equivalent

"In the SOLO-1 Phase 3 trial (n=671, adults with moderate-to-severe atopic dermatitis), patients treated with dupilumab 300 mg every two weeks achieved IGA 0/1 response in 38% of cases versus 10% for placebo at week 16 (p<0.001), as published in the New England Journal of Medicine (Simpson et al., 2016, PMID 27690741). The approved indication covers adults and adolescents aged 12 and older with inadequate response to topical therapies."

This version contains five retrievable elements: trial name, population, numeric outcome, comparator result, statistical significance, journal citation, and approval context. A retrieval engine can extract and verify each element independently. The MLR content is unchanged from the weak version — it is the same approved data. What has changed is structure and specificity, not substance.

Canonical claims: the four-element structure

The rewrite example above illustrates what we call the canonical claim — the unit of content that retrieval engines extract and cite. A strong canonical claim has four required elements:

1. Specific subject: brand name plus INN together (not "this drug" or "the treatment")
2. Precise predicate: numeric outcome with comparator, not directional language like "improved" or "showed benefit"
3. Specified population: the trial population or label indication, not "patients" generically
4. Embedded source: trial name or publication reference in the same sentence, not relegated to a footnote

The fourth element is critical given the Princeton finding on inline citation effect (+115.1% PAWC for mid-tier sources). Reference lists at the end of an article are often not indexed by retrieval engines; a claim whose evidence appears only in an endnote is treated as an unsupported assertion. Moving citation metadata inline — into the claim sentence itself — is the single structural change with the largest impact on retrieval probability.

Avoiding promotional language: the retrieval penalty

One of the most counterproductive patterns in GEO content is the use of promotional language. Superlatives and vague efficacy claims are not just regulatory risks — they are retrieval penalties. Content containing phrases like "market-leading," "unmatched efficacy," or "transformative for patients" is consistently deprioritised by retrieval engines in favour of neutral, data-grounded alternatives. The Princeton finding on keyword stuffing (-8.7% PAWC) extends to promotional density more broadly: content that reads as advertising is ranked lower than content that reads as clinical information.

The discipline of writing in clinical register, attributing all claims to specific data, and qualifying where evidence is limited is both good MLR practice and good GEO practice. The constraint is the same; the motivation is now doubled.

Checklist for retrieval-friendly medical writing

Apply this checklist at the drafting stage, before MLR submission. None of these items require reopening an approved document — they are structural choices available at the brief stage.

The MLR-plus-GEO workflow: where to integrate without rebuilding

Integrating GEO requirements into an existing MLR workflow requires two additions, not a rebuild. At the brief stage, add a GEO specification: the target query types this content must answer, the canonical claims required in the final piece, the heading structure, and the format specification (HTML-first, not PDF). At the post-approval stage, a GEO quality check — completed by a digital specialist, not the MLR team — verifies that headings are query-shaped, canonical claims are inline, and the page will index correctly. The MLR reviewer approves content; the GEO specialist approves format. Neither process touches the other. What changes is that both happen before publication, and the content arriving at the GEO gate is already structured for retrieval because it was briefed that way from the start.

Want a real audit on your brand? Request a sample report or get the full PharmaGEO Playbook.